With The Actual Controller Assist And Actress Liu Xiaoye Endorse, 9 New Products From Yuansu Brand Officially Launched

On January 26, Dongbao Biology (300239.SZ), which is deeply involved in the collagen health industry, 9 new products from "Yuansu" brand firstly be lanched, it includes 4 types of collagen shredded meat , beef bone collagen peptide powder, fish collagen peptide powder, collagen , protein peptide blueberry juice drink, collagen sodium hyaluronate vitamin C powder, etc., covering multiple categories such as nutrition products, health food, collagen shredded meat, etc. Dongbao Biology joined hands with Ms. Liu Xiaoye, a powerful actress from mainland China, to endorse the Yuansu brand. Ms. Xu Bo, one of the actual controllers of Dongbao Biology, served as the ambassador of Yuansu Collagen, which doubled to help the market sales of the company's products. Dongbao Biology will use this as an opportunity to continuously enhance brand awareness, further enhance the brand effect of "Yuansu" brand products, and promote the diversified application of collagen in "medicine, health, food, and beauty".

According to the data, Dongbao Biology is a leading enterprise in the gelatin industry in China, and one of the few A-share companies focusing on the whole collagen industry chain, forming a system from production ,R & D ,sales to service ,which includes high-quality bone facility,gelatin,collagen,nutritional health products,medicinal materials,beauty Cosmetic products and others, the system has covered ISO22000, FSSC9001, ISO22000, ISO14001, intellectual property management system certification.

Over the years, the company has always adhered to the mission of "focusing on collagen, constantly innovating, and pursuing health", centered on "collagen+", continued to strengthen independent research and development, and cooperated with the Institute of Physics and Chemistry of the Chinese Academy of Sciences, Baotou Institute of Light Industry, China Meat Research Center, Inner Mongolia Agricultural University and other advantages Business cooperation between universities and research institutions ,to develop innovative products and promote breakthroughs in collagen applications.

In the field of "collagen +" nutrition and health care field, the company further strengthened the in-depth exploration of the value of collagen as a health care product, and launched a series of new products such as bovine collagen peptide powder, fish collagen peptide powder, collagen peptide blueberry juice drink, collagen sodium hyaluronate vitamin C powder, the launched bovine bone collagen peptide powder of "Yuansu" brand is rich in 18 kinds of amino acids needed by the human body. The raw material is carefully selected and extracted from grassland fresh beef bone, realizing the creation and upgrading of raw materials for the production of collagen peptide , At the same time, the national invention patent directional enzyme digestion technology is used in the production process, and the small molecule peptides produced are easier for human body to absorb. "Yuansu" brand collagen shredded meat has 4 new varieties on the market this time, all of which are non-fried food, rich in animal and plant double protein, and each 100g contains 5000mg of collagen peptide. This product is a new collagen artificial meat product that adapts to people's modern dietary changes and dietary nutrition and health needs, combined with a personalized health food manufacturing strategy. It continues to enrich the "Yuansu" collagen product series and creates a growth pole for performance.

In the food field of "collagen +" , the company is currently the first enterprise in China ,which obtained the license for animal and plant double protein food production. "Yuansu" brand collagen shredded meat is a Dongbao biological animal and plant double protein collagen shredded meat product, which is in line with the "National Nutrition Plan (2017-2030)" to focus on the development of new nutritional and healthy foods such as double protein foods concept and direction. The launch of this product will further enrich the company's product structure. It is a new measure for company to expand new fields, meet new market demands, and increase the added value of the company's products. It further implements the company's layout in the fields of "medicine, health, food, and beauty" .

With the launch of new products, Dongbao Biology has also made diversified preparations for the subsequent online marketing. The company has fully grasped the dividends brought about by the development of e-commerce in recent years, and has made a lot of initial investment in channel construction, marketing planning, and resource matching. Set up locations in developed regions, build efficient marketing teams, and use e-commerce platforms, live broadcast platforms, Xiaohongshu and other publicity platforms to continue to build online channel barriers.

Meanwhile, in order to effectively integrate the business sector resources of the biomedicine and health care products ,and give full play to the business synergy effect of the gelatin industry chain, the company announced in the early stage that Gon Group (stock code: 002768) through the form of participation in fixed increase + agreement transfer, a total of With 21.18% of the company's shares, it becomes the company's controlling shareholder. The controlling shareholder, Gon Group has a background in the big chemical industry and is optimistic about the big health industry. Currently, it is actively building a dual-industry model of chemical and biomedical health products. The company will make full use of its high-quality industrial resources in the future, accelerate industrial integration, and exert business synergy with the company , expand the in-depth development of the collagen industry, and enhance the company's core competitiveness.

According to the Grand View Research report, the market size of China's collagen increased to US$983 million in 2019, accounting for about 6.40% of the global market; and by 2027, the market size of China's collagen is expected to reach US$1.576 billion, accounting for about 6.4% of the global market. 6.96%, and the average annual compound growth rate from 2016 to 2027 is 6.54%, which is higher than the global market growth rate of 5.42%.

Dongbao Biology is committed to building a world-class modern collagen biotechnology enterprise. Focusing on "collagen+", it will focus on the four major directions of medicine, health, food, and beauty in the future to maintain green, healthy and sustainable development. As the collagen market enters a period of rapid development, the application of collagen and its derivatives in functional fields such as medical health, food and beverages, and cosmetics is increasing day by day, and the company continues to increase the development of new markets special medical food, protein bars , meal replacement powder, textiles, pet functional food, etc., and constantly launch new products. With the "Yuansu" brand endorsement and the company's continuous increase in publicity, the company's revenue is expected to achieve continuous growth. The company strives to build the "Yuansu" brand into the first national brand in China's collagen industry, and accelerates its progress towards the grand goal of "a world-class modern collagen biotechnology enterprise".